Literature DB >> 22301158

Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells.

Dongli Pan1, Donald M Coen.   

Abstract

To be clinically relevant, drug-resistant mutants must both evade drug action and retain pathogenicity. Many acyclovir-resistant herpes simplex virus mutants from clinical isolates have one or two base insertions (G8 and G9) or one base deletion (G6) in a homopolymeric run of seven guanines (G string) in the gene encoding thymidine kinase (TK). Nevertheless, G8 and G9 mutants express detectable TK activity and can reactivate from latency in mice, a pathogenicity marker. On the basis of studies using cell-free systems, ribosomal frameshifting can explain this ability to express TK. To investigate frameshifting in infected cells, we constructed viruses that express epitope-tagged versions of wild-type and mutant TKs. We measured TK activity by plaque autoradiography and expression of frameshifted and unframeshifted TK polypeptides using a very sensitive immunoprecipitation-Western blotting method. The G6 mutant expressed ∼0.01% of wild-type levels of TK polypeptide. For the G9 mutant, consistent with previous results, much TK expression could be ascribed to reversion. For the G8 mutant, from these assays and pulse-labeling studies, we determined the ratio of synthesis of frameshifted to unframeshifted polypeptides to be 1:100. The effects of stop codons before or after the G string argue that frameshifting can initiate within the first six guanines. However, frameshifting efficiency was altered by stop codons downstream of the string in the 0 frame. The G8 mutant expressed only 0.1% of the wild-type level of full-length TK, considerably lower than estimated previously. Thus, remarkably low levels of TK are sufficient for reactivation from latency in mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301158      PMCID: PMC3318614          DOI: 10.1128/JVI.06995-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  The role of herpes simplex virus type 1 thymidine kinase in pathogenesis.

Authors:  S Efstathiou; S Kemp; G Darby; A C Minson
Journal:  J Gen Virol       Date:  1989-04       Impact factor: 3.891

2.  A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture.

Authors:  J G Jacobson; S L Martin; D M Coen
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Effect of an amber mutation in the herpes simplex virus thymidine kinase gene on polypeptide synthesis and stability.

Authors:  A F Irmiere; M M Manos; J G Jacobson; J S Gibbs; D M Coen
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

4.  A genetic approach to promoter recognition during trans induction of viral gene expression.

Authors:  D M Coen; S P Weinheimer; S L McKnight
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

5.  A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant.

Authors:  C B Hwang; B Horsburgh; E Pelosi; S Roberts; P Digard; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

6.  Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation.

Authors:  R B Tenser; W A Edris
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

7.  Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.

Authors:  D M Coen; A F Irmiere; J G Jacobson; K M Kerns
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

8.  Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.

Authors:  D M Coen; M Kosz-Vnenchak; J G Jacobson; D A Leib; C L Bogard; P A Schaffer; K L Tyler; D M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

9.  Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.

Authors:  C Danve-Szatanek; M Aymard; D Thouvenot; F Morfin; G Agius; I Bertin; S Billaudel; B Chanzy; M Coste-Burel; L Finkielsztejn; H Fleury; T Hadou; C Henquell; H Lafeuille; M E Lafon; A Le Faou; M C Legrand; L Maille; C Mengelle; P Morand; F Morinet; E Nicand; S Omar; B Picard; B Pozzetto; J Puel; D Raoult; C Scieux; M Segondy; J M Seigneurin; R Teyssou; C Zandotti
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

10.  HSV excretion after bone marrow transplantation: a 4-year survey.

Authors:  Florence Morfin; Karin Bilger; Anne Boucher; Anne Thiebaut; Fatiha Najioullah; Nathalie Bleyzac; Nicole Raus; Sylvie Bosshard; Michèle Aymard; Mauricette Michallet; Danielle Thouvenot
Journal:  J Clin Virol       Date:  2004-08       Impact factor: 3.168

View more
  13 in total

1.  Mutations Inactivating Herpes Simplex Virus 1 MicroRNA miR-H2 Do Not Detectably Increase ICP0 Gene Expression in Infected Cultured Cells or Mouse Trigeminal Ganglia.

Authors:  Dongli Pan; Jean M Pesola; Gang Li; Seamus McCarron; Donald M Coen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

2.  Herpes simplex virus is equipped with RNA- and protein-based mechanisms to repress expression of ATRX, an effector of intrinsic immunity.

Authors:  Igor Jurak; Leah B Silverstein; Mayuri Sharma; Donald M Coen
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

3.  The Current State of Vaccine Development for Ocular HSV-1 Infection.

Authors:  D J Royer; A Cohen; Djj Carr
Journal:  Expert Rev Ophthalmol       Date:  2015-04-01

4.  Neuronal miR-138 Represses HSV-2 Lytic Infection by Regulating Viral and Host Genes with Mechanistic Differences from HSV-1.

Authors:  Siyu Chen; Yue Deng; Hongjia Chen; Yuqi Lin; Xuewei Yang; Boqiang Sun; Dongli Pan
Journal:  J Virol       Date:  2022-04-11       Impact factor: 6.549

5.  Net -1 frameshifting on a noncanonical sequence in a herpes simplex virus drug-resistant mutant is stimulated by nonstop mRNA.

Authors:  Dongli Pan; Donald M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

6.  A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency.

Authors:  Dongli Pan; Omar Flores; Jennifer L Umbach; Jean M Pesola; Peris Bentley; Pamela C Rosato; David A Leib; Bryan R Cullen; Donald M Coen
Journal:  Cell Host Microbe       Date:  2014-04-09       Impact factor: 21.023

7.  Common and new acyclovir resistant herpes simplex virus-1 mutants causing bilateral recurrent herpetic keratitis in an immunocompetent patient.

Authors:  Dongli Pan; Stephen B Kaye; Mark Hopkins; Ruaidhri Kirwan; Ian J Hart; Donald M Coen
Journal:  J Infect Dis       Date:  2013-08-14       Impact factor: 5.226

8.  Regulation of host and virus genes by neuronal miR-138 favours herpes simplex virus 1 latency.

Authors:  Boqiang Sun; Xuewei Yang; Fujun Hou; Xiaofeng Yu; Qiongyan Wang; Hyung Suk Oh; Priya Raja; Jean M Pesola; Emilia A H Vanni; Seamus McCarron; Jenna Morris-Love; Alex H M Ng; George M Church; David M Knipe; Donald M Coen; Dongli Pan
Journal:  Nat Microbiol       Date:  2021-02-08       Impact factor: 17.745

9.  Ribosomal frameshifting used in influenza A virus expression occurs within the sequence UCC_UUU_CGU and is in the +1 direction.

Authors:  A E Firth; B W Jagger; H M Wise; C C Nelson; K Parsawar; N M Wills; S Napthine; J K Taubenberger; P Digard; J F Atkins
Journal:  Open Biol       Date:  2012-10       Impact factor: 6.411

Review 10.  New strategies against drug resistance to herpes simplex virus.

Authors:  Yu-Chen Jiang; Hui Feng; Yu-Chun Lin; Xiu-Rong Guo
Journal:  Int J Oral Sci       Date:  2016-03-30       Impact factor: 6.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.